Skip Navigation


Hum. Reprod. Advance Access originally published online on May 2, 2008
Human Reproduction 2008 23(7):1511-1519; doi:10.1093/humrep/den172
This Article
Right arrow Full Text
Right arrow Full Text (PDF )
Right arrow All Versions of this Article:
23/7/1511    most recent
den172v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hapangama, D.K.
Right arrow Articles by Von Zglinicki, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hapangama, D.K.
Right arrow Articles by Von Zglinicki, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length

D.K. Hapangama1,4, M.A. Turner1, J.A. Drury1, S. Quenby1, G. Saretzki2, C. Martin-Ruiz3 and T. Von Zglinicki3

1 School of Reproductive and Developmental Medicine, University of Liverpool, Liverpool Women's Hospital, Crown Street, Liverpool L8 7SS, UK 2 Crucible Laboratory, Life Knowledge Park, University of Newcastle, Newcastle upon Tyne NE4 6BE, UK 3 Henry Wellcome Laboratory for Biogerontology Research, University of Newcastle, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE, UK

4 Correspondence address. E-mail: dharani.hapangama{at}liverpool.ac.uk

BACKGROUND: In order to test our hypothesis that endometriosis is associated with abnormal expression of telomerase and telomere lengthening in endometrium, we assessed endometrial expression of the human telomerase enzyme and telomere length (TL).

METHODS: This prospective pilot study, included 29 women with symptomatic, surgically diagnosed endometriosis (Group 1) and 27 healthy, fertile, symptom-free women without endometriosis (Group 2, confirmed by laparoscopy). Seventeen women in Group 1 and 15 women in Group 2 had endometrial biopsies taken on Day 21 ± 2 of the cycle. A further 12 women in each group were biopsied on Day 26 ± 2. Telomerase and estrogen receptor beta (ERβ) expression was evaluated by immunohistochemistry. Mean TL was determined by quantitative PCR.

RESULTS: The endometria of fertile healthy women showed either weak or no telomerase immunoreactivity throughout the luteal phase. Immunostaining for telomerase was significantly increased during the implantation window and the premenstrual endometria of women with endometriosis (P < 0.0001). This was associated with a loss of stromal and vascular ERβ immunostaining (P < 0.05). The mean TL were significantly longer in endometria of women with endometriosis during the implantation window (P = 0.005), indicating the biological relevance of our novel finding of telomerase in benign endometrium. There was positive correlation of the circulating estradiol with peripheral blood TL in women.

CONCLUSIONS: We speculate that aberrant endometrial expression of telomerase mediates alterations in cell fate that enhance proliferation, contributing to the pathogenesis of endometriosis.

Key words: telomerase/endometriosis/telomere length/telomerase repeat amplification protocol/secretory phase endometrium

Submitted on July 16, 2007; resubmitted on February 10, 2008; accepted on April 8, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.